PCV44 Economic Evaluation of a Single-Pill Triple Combination With Valsartan, Amlodipine and Hydrochlorothiazide Against Its Dual Components in Greece. The Generic Substitution Case
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.987
https://www.valueinhealthjournal.com/article/S1098-3015(12)02700-3/fulltext
Title :
PCV44 Economic Evaluation of a Single-Pill Triple Combination With Valsartan, Amlodipine and Hydrochlorothiazide Against Its Dual Components in Greece. The Generic Substitution Case
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)02700-3&doi=10.1016/j.jval.2012.08.987
First page :
A370
Section Title :
Cardiovascular Disorders
Open access? :
No
Section Order :
492